1. Home
  2. BLNK vs XOMA Comparison

BLNK vs XOMA Comparison

Compare BLNK & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blink Charging Co.

BLNK

Blink Charging Co.

HOLD

Current Price

$0.69

Market Cap

89.3M

ML Signal

HOLD

Logo XOMA Corporation

XOMA

XOMA Corporation

HOLD

Current Price

$26.01

Market Cap

397.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLNK
XOMA
Founded
2009
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
89.3M
397.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BLNK
XOMA
Price
$0.69
$26.01
Analyst Decision
Buy
Strong Buy
Analyst Count
7
4
Target Price
$2.13
$63.25
AVG Volume (30 Days)
7.6M
99.2K
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.82
Revenue
$106,631,000.00
$47,106,000.00
Revenue This Year
N/A
$77.29
Revenue Next Year
$17.87
$34.91
P/E Ratio
N/A
$31.72
Revenue Growth
N/A
118.02
52 Week Low
$0.63
$18.35
52 Week High
$2.65
$39.92

Technical Indicators

Market Signals
Indicator
BLNK
XOMA
Relative Strength Index (RSI) 23.85 38.33
Support Level $0.77 $25.04
Resistance Level $0.85 $26.24
Average True Range (ATR) 0.07 1.49
MACD -0.01 -0.06
Stochastic Oscillator 3.47 12.12

Price Performance

Historical Comparison
BLNK
XOMA

About BLNK Blink Charging Co.

Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns a majority of revenue from U.S.A.

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Share on Social Networks: